The α2‐AR agonist guanfacine is an anti‐anxiety and depression drug, and it is reported that the key to guanfacine in the treatment of anxiety and depression lies in activating α2‐AR in the amygdala. This evidence concerns the gene ADORA2A and major depressive disorder.